newsfilter
← Latest News
GlobeNewswire·

Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026

DURHAM, N.C., May 01, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE:PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs ("Pelthos"), today